BI 99179 (C09-1113-346)

BI 99179 is a potent and selective type I fatty acid synthase ( FAS ) inhibitor with an IC 50 of 79 nM. BI 99179 is a tool compound suitable for the in vivo validation of FAS as a target for lipid metabolism related diseases. BI 99179 exhibits significant exposure (both peripheral and central) upon oral administration in ratsIn VitroBI 99179 is potent in the mouse hypothalamic N-42 cell with an IC 50 of 0.6 μM. BI 99179 shows no significant LDH release in the cytotoxicity assay up to 30 μM. BI 99179 (BI-99179; 1, 2, and 4 µM) shows antiproliferative efficacy in human glioma GAMG cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Proliferation AssayCell Line: Human glioma GAMG cells Concentration: 1, 2, 4 µM Incubation Time: 96 to 120 hours Result: The optimal palmitate concentration for GAMG cell line was 4 µM.In VivoBI 99179 has a super pharmacokinetic profile in male Han/Wistar rats (oral application of 4 mg/kg) with half life (t 1/2 ) of 3.0 h . MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:SolidIC50& Target:IC50: 79 nM (FASN). Specification: 0.99 Molecular Formula: C23H25N3O3 Molecular Weight: 391.46 PubChem CID: 51346964 Isomeric SMILES: CCC(=O)N[C@H]1CC[C@H](C1)C(=O)N(C)C2=CC=C(C=C2)C3=NC4=CC=CC=C4O3